KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate under regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 KILITCH DRUGS (INDIA) LTD. - 524500 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newpaper Publication of extract of Financial Results for the quarter ended 30th June, 2023 KILITCH DRUGS (INDIA) LTD. - 524500 - Board Meeting Outcome for Outcome Of Board Meeting
Details of the agenda approved at the meeting is enclosed herewith KILITCH DRUGS (INDIA) LTD. - 524500 - Board Meeting Outcome for Outcome Of Board Meeting
Details of the agenda approved at the meeting is enclosed herewith KILITCH DRUGS (INDIA) LTD. - 524500 - Considered And Approved Unaudited Financials Results For The Quarter Ended 30Th June, 2023
Considered and approved financial results for the quarter ended 30th June, 2023 KILITCH DRUGS (INDIA) LTD. - 524500 - Board Meeting Intimation for To Consider And Approve Unaudited Results For The Quarter Ended 30Th June 2023
KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the meeting of the Board of Directors of the Company will be held on Friday, 11th August, 2023 inter-alia to consider and approve the unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th June, 2023. KILITCH DRUGS (INDIA) LTD. - 524500 - Board Meeting Outcome for Outcome Of Board Meeting
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. Saturday, 29th July, 2023 considered and approved obtaining credit facilities from bank, in aggregate, not exceeding Rs. 100 crore for the purpose of meeting fund requirements of the company. KILITCH DRUGS (INDIA) LTD. - 524500 - Board Meeting Outcome for Outcome Of Board Meeting
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. Saturday, 22nd July, 2023 considered and approved the following; Obtaining credit facilities from bank not exceeding Rs. 50,50,00,000 for the purpose of meeting day to day fund requirements of the Company. Conversion of 5,00,000 convertible warrants into 5,00,000 equity shares of face value of Rs. 10/- each of the Company out of the warrants allotted on 24th January, 2023 on preferential allotment basis to the allottees pursuant to exercise of their rights of conversion of warrants into equity shares and accordingly the Board of Directors have allotted 5,00,000 equity shares of face value of Rs. 10 each fully paid up on account of conversion KILITCH DRUGS (INDIA) LTD. - 524500 - Board Meeting Intimation for To Consider And Approve Conversion Of Warrants Into The Equity Shares Of The Company To The Specified Person Only
KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2023 ,inter alia, to consider and approve To consider and approve conversion of warrants into the equity shares of the Company to the specified person only KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018